semaglutide keto Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Unveiling Semaglutide and Embracing a

Gastrointestinal side-effects can last a few weeks but usually resolve on their own unless a higher dose is taken

Novak M, Monkus EF, Buch M, and et al

Discovery of antioxidant peptides from Amphibians: a review

But we are also seeing other injectable medications in testing that might be more powerful than whats already on the market

Common side effects during the adjustment period (typically the first 24 weeks): Mild nausea usually less intense than when first starting a GLP-1 medication Changes in appetite (some patients notice less appetite suppression early on at the starting 0.25 mg dose) Mild stomach discomfort, bloating, or constipation Injection site reactions Side effects that are less likely during the switch (compared to first-time GLP-1 use), but still possible: Significant vomiting less common given prior GLP-1 exposure, but possible Hypoglycemia particularly relevant for type 2 diabetes patients on insulin or sulfonylureas